Construction completes on Moderna’s innovation centre at Harwell

Moderna has announced the completion of construction of its new innovation and technology centre at Harwell Campus.

Stakeholders from across the UK life sciences industry celebrated the milestone.

The Moderna Innovation and Technology Centre (MITC) will be the company’s state-of-the-art research, development and manufacturing base.

A 10-year partnership with the UK Government – managed by the UK Health Security Agency (UKHSA) – has enabled the investment.

Darius Hughes, general manager of Moderna UK, said: ” We have made remarkable progress since initiating our unique strategic partnership with the UK government two years ago. Later this year, this state-of-the-art facility will be ready to deliver British-made Covid-19 vaccines, ensuring a robust supply for the UK public.

“Through our partnership, Moderna is committed to becoming an integral part of the UK’s world-leading life sciences ecosystem, working in partnership with the Government, academia, and the NHS to explore the full potential of our mRNA platform and co-develop solutions to help transform UK healthcare.”

Sign up to receive our weekly free journal, The Forum here.